Scilex, a publicly traded company, plans to sell shares in its holding subsidiary in exchange for $200 million worth of Bitcoin.
-
最新报道：Scilex Holding Company (NASDAQ: SCLX), an innovative revenue-generating company, has signed a securities purchase agreement ("SPA") with an institutional investor to exchange $200 million worth of common stock in its majority-owned subsidiary, Semnur Pharmaceuticals, Inc., for $200 million worth of Bitcoin. Under the agreement, the institutional investor will purchase 12,500,000 shares of Semnur common stock held by Scilex at $16 per share. The transaction is expected to close on or about September 23, 2025.
下一篇
Polkadot (DOT) Price Reacts to Biggest Tokenomics Overhaul, $6 Retest Incoming?
- Polkadot has set a permanent supply cap of 2.1 billion DOT tokens, with approximately 1.6 ...
24小时热点
热点专题
418154